NCT07486037Recruiting
Caring for Caregivers of Individuals With Alzheimer's Disease
Caring for Caregivers of Individuals With Alzheimer's Disease- Promoting Virtual Home-based Exercise for Caregiver Wellbeing
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
What is this study about? This study is called the EMBRACE Study - A Virtual Community Empowerment Approach Integrating Tradition and Technology for Family Caregivers of Individuals with Alzheimer's Disease. It tests whether a home-based virtual exercise program can reduce depression and anxiety in family caregivers of people living with Alzheimer's disease and related dementias (ADRD). Why is this study needed? Caring for a loved one with ADRD is demanding and is strongly linked to depression and anxiety. Regular exercise is one of the most effective ways to reduce these symptoms - but caregivers often cannot leave home to exercise due to the needs of their loved one, transportation concerns, and safety issues. What does participation involve? Participants will be randomly assigned (like a coin flip) to one of two groups: * EMBRACE group: 24 weekly virtual group exercise sessions over 3 months (about 1 hour each), using an at-home elliptical device provided by the study. Months 4-6 include weekly check-in calls to support independent exercise. Educational sessions on habit-building and goal-setting are included. * Wait-list control group: Completes the same surveys and measurements; receives the program after data collection ends. Who can join? Adults (18+) who are the primary unpaid caregiver for someone with ADRD, can read and speak English, and are healthy enough to exercise. Participants do not need to leave home - everything is virtual. What is being measured? Exercise time (using a wearable device), symptoms of depression and anxiety, and whether the program is feasible and acceptable to participants. Where is the study based? Indiana University Indianapolis. The study is conducted entirely virtually and remotely.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- First submitted
- 14 Mar 2026
- Start date
- 1 Mar 2026
- Primary completion date
- 1 May 2028
- Lead sponsor
- Indiana University
- Diseases
- Alzheimer disease
- NCT number
- NCT07486037
What you commit to
- Study type: Interventional
- Planned participants: 25
- From 1 Mar 2026 to the primary completion date, 1 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving advanced cancer treatment or hospice care
- Currently receiving dialysis
Other illness
- Diagnosed psychiatric illness
- Severe vision impairment without corrective eyeglasses
Other
- Untreated severe major depression
- Severe hearing loss without hearing aids
- No access to a phone or email
- Unable to safely exercise based on PAR-Q+ screening
- Already meeting the recommended physical activity guidelines at the time of enrollment
Who the study is looking for
- Self-identifies as African American
- Age 18 years or older
- Primary unpaid caregiver for an adult living with Alzheimer's disease or a related dementia (ADRD)
- Able to read and speak English
- Deemed sufficiently healthy to participate in exercise per the PAR-Q+ screening questionnaire
- Has access to an email address
Age in the registry: 18 years to 99 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| School of Health and Human Sciences Coordinator of this site? Confirm its status | Indianapolis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.